(Q36316580)

English

Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation (English)

1 reference

Europe PubMed Central

13 August 2017

1 reference

based on heuristic

inferred from title

metastatic breast cancer

1 reference

based on heuristic

inferred from title

object named as

Evan N Cohen

4

0 references

Antonio Giordano

object named as

Antonio Giordano

6

0 references

Gabriel N Hortobagyi

11

object named as

Gabriel N Hortobagyi

1 reference

Europe PubMed Central

13 August 2017

Richard E Champlin

10

object named as

Richard E Champlin

1 reference

Europe PubMed Central

13 August 2017

author name string

Michal Mego

1

1 reference

Europe PubMed Central

13 August 2017

Hui Gao

2

1 reference

Europe PubMed Central

13 August 2017

Bang-Ning Lee

3

1 reference

Europe PubMed Central

13 August 2017

Sanda Tin

5

1 reference

Europe PubMed Central

13 August 2017

Qiong Wu

7

1 reference

Europe PubMed Central

13 August 2017

Ping Liu

8

1 reference

Europe PubMed Central

13 August 2017

Yago Nieto

9

1 reference

Europe PubMed Central

13 August 2017

Massimo Cristofanilli

12

1 reference

Europe PubMed Central

13 August 2017

Naoto T Ueno

13

1 reference

Europe PubMed Central

13 August 2017

James M Reuben

14

1 reference

Europe PubMed Central

13 August 2017

publication date

8 September 2012

1 reference

Europe PubMed Central

13 August 2017

Journal of Cancer

1 reference

Europe PubMed Central

13 August 2017

3

1 reference

Europe PubMed Central

13 August 2017

369-380

1 reference

Europe PubMed Central

13 August 2017

Long-term outcome of patients with metastatic breast cancer treated with high-dose chemotherapy and transplantation of purified autologous hematopoietic stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471078

30 September 2017

Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471078

30 September 2017

Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471078

30 September 2017

Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471078

30 September 2017

Molecular mechanisms of metastasis in breast cancer--clinical applications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471078

30 September 2017

Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471078

30 September 2017

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471078

30 September 2017

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471078

30 September 2017

The epithelial-mesenchymal transition generates cells with properties of stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471078

30 September 2017

The transcriptional repressor Snail promotes mammary tumor recurrence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471078

30 September 2017

CXCR4 regulates growth of both primary and metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471078

30 September 2017

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471078

30 September 2017

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471078

30 September 2017

Epithelial-mesenchymal transitions in development and pathologies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471078

30 September 2017

G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471078

30 September 2017

High-dose chemotherapy with hematopoietic stem-cell transplantation for breast cancer: current status, future trends

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471078

30 September 2017

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471078

22 September 2018

A pooled analysis of bone marrow micrometastasis in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471078

22 September 2018

Micrometastases in apheresis products predict shorter progression-free and overall survival in patients with breast cancer undergoing high-dose chemotherapy (HDCT) and autologous blood stem cell transplantation (ABSCT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471078

22 September 2018

Breast cancer cell contamination of blood stem cell products in patients with metastatic breast cancer: predictors and clinical relevance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471078

22 September 2018

Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23074378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose chemotherapy in patients with breast cancer: evaluation of infusing peripheral blood stem cells containing occult tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23074378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Occult tumor contamination of hematopoietic stem-cell products does not affect clinical outcome of autologous transplantation in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23074378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection

1 reference

https://pubmed.ncbi.nlm.nih.gov/23074378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte-macrophage colony-stimulating factor for autologous transplantation in advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23074378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques

1 reference

https://pubmed.ncbi.nlm.nih.gov/23074378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23074378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23074378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.7150/JCA.5111

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36316580&oldid=1809590144"